| domain | cslbehring.sa |
| summary | CSL (2026CSL) is a biotechnology company focused on developing and commercializing therapies for cardiovascular diseases, particularly in the areas of:
* Treating Heart Failure: They’re developing therapies to improve the heart’s ability to pump blood and manage symptoms of heart failure. * Cardiovascular Interventions: CSL develops and markets cardiovascular devices, including Amplathel® cardiac patches for congenital heart defects, and other products for treating heart rhythm disorders. * Immunology: CSL Plasma is a key part of the company, producing plasma-derived therapies used to treat immune deficiencies and autoimmune diseases.
Essentially, CSL’s diverse portfolio addresses critical unmet needs in both cardiovascular and immunological health. |
| title | CSL Behring Saudi Arabia |
| description | CSL Behring Saudi Arabia |
| keywords | rights, english |
| upstreams |
|
| downstreams |
|
| nslookup | A 12.3.33.221 |
| created | 2026-02-15 |
| updated | 2026-02-15 |
| summarized | 2026-02-16 |
|
|